rs17752991
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_138694.4(PKHD1):c.9492C>T(p.Ser3164Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000921 in 1,613,830 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_138694.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
- polycystic kidney disease 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- Caroli diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PKHD1 | ENST00000371117.8 | c.9492C>T | p.Ser3164Ser | synonymous_variant | Exon 58 of 67 | 1 | NM_138694.4 | ENSP00000360158.3 | ||
| PKHD1 | ENST00000340994.4 | c.9492C>T | p.Ser3164Ser | synonymous_variant | Exon 58 of 61 | 5 | ENSP00000341097.4 |
Frequencies
GnomAD3 genomes AF: 0.00108 AC: 164AN: 152144Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00182 AC: 457AN: 250854 AF XY: 0.00173 show subpopulations
GnomAD4 exome AF: 0.000904 AC: 1321AN: 1461568Hom.: 4 Cov.: 33 AF XY: 0.000871 AC XY: 633AN XY: 727126 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00108 AC: 165AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.00133 AC XY: 99AN XY: 74448 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive polycystic kidney disease Benign:4
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
- -
not specified Benign:2
- -
Variant summary: PKHD1 c.9492C>T alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0018 in 282262 control chromosomes, predominantly within the East Asian subpopulation at a frequency of 0.018 in the gnomAD database, including 2 homozygotes. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 2.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in PKHD1 causing Polycystic Kidney and Hepatic Disease phenotype (0.0071), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. Moreover, the variant was also reported in Japanese healthy controls with a frequency of 0.0256 (including 2 homozygotes) that is approximately 3.6-fold higher than the estimated maximal expected allele frequency for a pathogenic PKHD1 variant, further supporting that the variant is a benign polymorphism found primarily in populations of East Asian origin (HGVD). c.9492C>T has also been reported in the literature in healthy control individuals (e.g. Furu 2003, Bergmann 2005). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
not provided Benign:1
- -
Polycystic kidney disease 4 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at